274 related articles for article (PubMed ID: 18715649)
1. Efficacy of linezolid alone and in combination with rifampin in staphylococcal experimental foreign-body infection.
Murillo O; Domenech A; Euba G; Verdaguer R; Tubau F; Cabo J; Cabellos C; Gudiol F; Ariza J
J Infect; 2008 Sep; 57(3):229-35. PubMed ID: 18715649
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of linezolid in the treatment of mediastinitis due to methicillin-resistant Staphylococcus aureus: an experimental study.
Sacar M; Sacar S; Kaleli I; Cevahir N; Teke Z; Kavas ST; Asan A; Aytekin FO; Baltalarli A; Turgut H
Int J Infect Dis; 2008 Jul; 12(4):396-401. PubMed ID: 18162429
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus.
Garrigós C; Murillo O; Euba G; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J
J Infect; 2011 Sep; 63(3):229-35. PubMed ID: 21763722
[TBL] [Abstract][Full Text] [Related]
6. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.
Baldoni D; Haschke M; Rajacic Z; Zimmerli W; Trampuz A
Antimicrob Agents Chemother; 2009 Mar; 53(3):1142-8. PubMed ID: 19075065
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection.
Trampuz A; Murphy CK; Rothstein DM; Widmer AF; Landmann R; Zimmerli W
Antimicrob Agents Chemother; 2007 Jul; 51(7):2540-5. PubMed ID: 17502404
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; Orlando F; Del Prete MS; D'Amato G; Silvestri C; Saba V; Scalise G
J Antimicrob Chemother; 2003 Oct; 52(4):724-6. PubMed ID: 12951347
[TBL] [Abstract][Full Text] [Related]
9. In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Jacqueline C; Asseray N; Batard E; Le Mabecque V; Kergueris MF; Dube L; Bugnon D; Potel G; Caillon J
Int J Antimicrob Agents; 2004 Oct; 24(4):393-6. PubMed ID: 15380267
[TBL] [Abstract][Full Text] [Related]
10. Intracellular antimicrobial activity appearing as a relevant factor in antibiotic efficacy against an experimental foreign-body infection caused by Staphylococcus aureus.
Murillo O; Pachón ME; Euba G; Verdaguer R; Carreras M; Cabellos C; Cabo J; Gudiol F; Ariza J
J Antimicrob Chemother; 2009 Nov; 64(5):1062-6. PubMed ID: 19744977
[TBL] [Abstract][Full Text] [Related]
11. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
[TBL] [Abstract][Full Text] [Related]
12. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis.
Dailey CF; Pagano PJ; Buchanan LV; Paquette JA; Haas JV; Gibson JK
Antimicrob Agents Chemother; 2003 Aug; 47(8):2655-8. PubMed ID: 12878535
[TBL] [Abstract][Full Text] [Related]
14. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
Yin LY; Calhoun JH; Thomas TS; Wirtz ED
J Antimicrob Chemother; 2009 Feb; 63(2):357-60. PubMed ID: 19060292
[TBL] [Abstract][Full Text] [Related]
16. Glycopeptide insensitive Staphylococcus aureus subdural empyema treated with linezolid and rifampicin.
Gallagher RM; Pizer B; Ellison JA; Riordan FA
J Infect; 2008 Nov; 57(5):410-3. PubMed ID: 18703232
[TBL] [Abstract][Full Text] [Related]
17. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
De Cock E; Sorensen S; Levrat F; Besnier JM; Dupon M; Guery B; Duttagupta S
Med Mal Infect; 2009 May; 39(5):330-40. PubMed ID: 19304423
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M
Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
[TBL] [Abstract][Full Text] [Related]
20. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
